Stock Market News for July 23, 2026
884 news published.
Big Tech, defense and transport: quarterly beats and guidance cues
RTX (RTX) released Q2 2026 results, with cash flow and backlog under the microscope for defense spending trends and margin outlook across aerospace services.
Lockheed Martin (LMT) reported Q2 results, highlighting program timing sensitivity that matters for backlog-to-cash conversion in prime defense contractors.
Union Pacific (UNP) and Norfolk Southern (NSC) published second-quarter operational prints (UNP Q2, NSC Q2) that continue to steer investor allocation across industrials and transport.
AI infrastructure and semiconductors: product cadence and a major earnings beat
AMD (AMD) rolled out a full-stack AI compute vision and teamed with Cerebras on low-latency inference, strengthening its datacenter CPU and inference positioning.
Intel (INTC) reported Q2 2026 results. The update matters for chip supply, foundry cadence and capital spending assumptions across AI infrastructure vendors.
Supermicro (SMCI) introduced servers built on 6th Gen AMD EPYC, touting ~1.7x generational throughput—an OEM datapoint for enterprise AI refresh cycles.
Amkor Technology (AMKR) struck a strategic partnership with NVIDIA to expand advanced packaging and test for next‑generation AI infrastructure. That tie-up is meaningful for outsourced semiconductor assembly and test (OSAT) capacity and for investors tracking the supply chain that feeds datacenter accelerators.
Signals beyond hyperscalers—QumulusAI’s $32M NVIDIA pact and Skyworks’ NetSync—point to sustained demand for AI hardware and components.
AI policy, government procurement and biotech AI
Right2Compute (ALP) launched a coalition pushing sovereign control and data residency—an investor-relevant angle for onshore cloud and defense-related data center strategies.
The U.S. Department of War moved to speed procurement of Oracle (ORCL) solutions via an enterprise software initiative, underscoring how government buying can shift enterprise software revenue and contract visibility for defense and intelligence-related IT vendors.
On the biology front, eXoZymes (EXOZ) was selected for the DOE’s Genesis Mission to build AI-powered digital twins for cell-free biomanufacturing—a sign that AI is extending into biotech process scale-up and industrialization.
Energy, clean power, advanced nuclear and data-center demand
Digital Realty (DLR) reported Q2 2026 results, a key read for hyperscale leasing, interconnection revenue and how wholesale data-center demand feeds utility planning.
Duke Energy (DUK) argued that data-center growth will deliver billions in customer savings, linking renewables and large-scale compute to utility rate-base narratives.
Oklo (OKLO) received DOE startup authorization for its Groves reactor, clearing the way for fuel loading and first criticality—an important regulatory milestone for advanced nuclear and long-duration clean power prospects.
Expro (XPRO) completed the acquisition of Enhanced Drilling, a consolidation move in energy services that could affect offshore and onshore drilling capacity and cash-flow profiles.
Freeport-McMoRan (FCX) reported Q2 operating metrics (details) that keep copper supply dynamics in focus for industrial and EV demand.
Ovintiv (OVV) reported Q2 2026 financial and operating results, a useful datapoint for U.S. E&P cash flow, capital spending and production assumptions amid the energy transition narrative.
Materials and mining: defense battery supply and battery minerals
EnerSys (ENS) refined plans for a defense‑focused lithium cell manufacturing facility with DOE support—news that matters for secure battery supply chains and military electrification targets.
Newmont (NEM) reported robust Q2 2026 results and reaffirmed guidance—relevant for gold exposure and mining cash-flow expectations.
Healthcare, biotech, trial readouts and corporate moves
Johnson & Johnson (JNJ) said TECVAYLI® + TALVEY® cut progression or death by 89% in earlier-line multiple myeloma—a clinical result that could reshape adoption and long-term oncology revenue models.
Lilly (LLY) notched two Phase 3 wins with retatrutide, reinforcing the obesity-drug growth story and its implications for future guidance.
GE HealthCare (GEHC) reported preliminary Q2 results and announced a CFO transition, items investors watch for near-term guidance and capital allocation across imaging and service businesses.
Instinct Bio / Relativity (ACQC) completed its business combination and debuted on Nasdaq as “BIOT”, a notable biotech listing that may attract investor attention to cell therapy and platform plays.
Edwards Lifesciences (EW) reported Q2 results, relevant to device demand and procedural volumes in structural heart markets.
Tenet (THC) reported robust Q2 results and raised its 2026 outlook, a meaningful datapoint for hospital operator margins and elective-care recovery.
Financial results, capital actions and market plumbing
Nasdaq (NDAQ) posted Q2 revenue of $1.5B, with listings and data businesses supporting recurring cash flow.
SS&C Technologies (SSNC) released record Q2 2026 results, reinforcing software-driven scale in asset servicers and implications for recurring revenue multiples.
Charter (CHTR) launched debt exchange offers, a capital-structure move that investors will parse for refinancing risk and interest-cost trajectories.
ADTRAN (ADTN) strengthened its balance sheet with a new senior secured credit facility, an action that eases near-term liquidity pressure while supporting network investment plans.
Eos Energy (EOSE) closed a rights offering above $250M, shoring liquidity for battery deployment.
Consumer, retail and travel signals
T-Mobile (TMUS) posted continued account growth and service-revenue strength (release), a steadying factor for wireless services.
Boston Beer (SAM) reported Q2 results, a demand barometer for beverage categories as summer and on-premise trade evolve.
Marriott (MAR) signed a deal to expand all-inclusive resorts with Catalonia (agreement), a fee-driven growth move amid seasonal travel shifts.
Align Technology (ALGN) announced new Invisalign platform innovations, a product cadence item that can influence patient adoption and chair-side economics for orthodontists.
Infrastructure, M&A and contract updates
Ocean Power Technologies (OPTT) announced FY 2026 results, while Expro (XPRO)’s deal completion underscores ongoing consolidation in energy services.
Safety Insurance Group (SAFT) agreed to be acquired by Mapfre for $1.54 billion. That transaction is a notable insurance-sector M&A event and will be watched for pricing precedent among regional carriers.
Market signals to watch today
- Semiconductor and AI supply chains: Intel’s Q2, AMD product deals and Amkor’s NVIDIA pact shape expectations for capex and OSAT capacity.
- Data-center footprint & grid investment: Digital Realty and utility commentary link hyperscale leasing to long-term infrastructure spend.
- Energy transition & advanced nuclear: Oklo’s DOE authorization and battery-factory plans from EnerSys are meaningful for clean-power capacity and supply security.
- Healthcare catalysts: J&J’s myeloma readout, Lilly’s obesity wins and GE HealthCare’s leadership and preliminary results will influence health-care allocations.
- Capital structure and M&A: Charter’s exchange, ADTRAN’s facility and the Mapfre–Safety Insurance deal are key signals for financing and consolidation trends.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement






































































































































































































































































































































































































































































































































































































































































































































































































































